Hb Canterbury [beta112(G14)Cys-->Phe]: a new, mildly unstable variant.
Brennan
Stephen O
SO
Molecular Pathology Laboratory, Canterbury Health Laboratories, Christchurch, New Zealand. steve.brennan@chmeds.ac.nz
Potter
Howard C
HC
Kubala
Lia M
LM
Carnoutsos
Susan A
SA
Ferguson
Martin M
MM
D019840:2-Propanol / Q000494:pharmacology; D019943:Amino Acid Substitution; D011232:Chemical Precipitation; D005914:Globins / Q000737:chemistry / Q000235:genetics*; D006223:Hamartoma Syndrome, Multiple / Q000097:blood / Q000150:complications; D006455:Hemoglobins, Abnormal / Q000737:chemistry / Q000235:genetics / Q000302:isolation & purification*; D006801:Humans; D008297:Male; D008875:Middle Aged; D020125:Mutation, Missense; D010449:Peptide Mapping; D017354:Point Mutation; D011489:Protein Denaturation; D021241:Spectrometry, Mass, Electrospray Ionization
D006455:Hemoglobins, Abnormal; C465355:hemoglobin Canterbury; D005914:Globins; D019840:2-Propanol